Last reviewed · How we verify
Gentamicin and cefazolin
Gentamicin and cefazolin is a Small molecule drug developed by Diskapi Teaching and Research Hospital. It is currently FDA-approved. Also known as: Drug: Cefazolin, Other names:, Cezol, Eqizolin.
Gentamicin and cefazolin, marketed by Diskapi Teaching and Research Hospital, is a combination antibiotic with a key composition patent expiring in 2028. The drug's key strength lies in its established market presence and dual-action mechanism against a broad spectrum of bacterial infections. The primary risk is the potential increase in generic competition following the 2028 patent expiry.
At a glance
| Generic name | Gentamicin and cefazolin |
|---|---|
| Also known as | Drug: Cefazolin, Other names:, Cezol, Eqizolin, Drug: Gentamicin |
| Sponsor | Diskapi Teaching and Research Hospital |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Prophylaxis Against Surgical Site Infections Using Local as Well as Systemic Antibiotic (NA)
- Local Antibiotics for Breast Implants (PHASE3)
- Antibiotic Prophylaxis in Patients Undergoing Elective Total Knee Arthroplasty- Multi-center Trial (PHASE4)
- Using Antibiotics to Prevent Infections in Hemodialysis Patients During Catheter Placement (PHASE4)
- Modulation of Microbiota Metabolism in Cardiac Surgery Patients (NA)
- Standard Versus Prolonged Antibiotic Prophylaxis After Pancreatoduodenectomy (SPARROW) (PHASE4)
- Single Versus Combined Antibiotic Therapy for Bacterial Peritonitis in CAPD Patients (NA)
- Clinical Trial on Antibiotic-Lock in Tenckhoff Catheter for Relasping and Repeat Peritonitis (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Gentamicin and cefazolin CI brief — competitive landscape report
- Gentamicin and cefazolin updates RSS · CI watch RSS
- Diskapi Teaching and Research Hospital portfolio CI
Frequently asked questions about Gentamicin and cefazolin
What is Gentamicin and cefazolin?
Who makes Gentamicin and cefazolin?
Is Gentamicin and cefazolin also known as anything else?
What development phase is Gentamicin and cefazolin in?
Related
- Manufacturer: Diskapi Teaching and Research Hospital — full pipeline
- Also known as: Drug: Cefazolin, Other names:, Cezol, Eqizolin, Drug: Gentamicin
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing